Follitropin Delta in Long GnRH Agonist and GnRH Antagonist Protocols (BEYOND)
Status:
Recruiting
Trial end date:
2022-09-30
Target enrollment:
Participant gender:
Summary
To compare the efficacy and safety of FE 999049 (follitropin delta) and its personalized
dosing algorithm in controlled ovarian stimulation for in vitro fertilization
(IVF)/intracytoplasmic sperm injection (ICSI) using a long gonadotropin-releasing hormone
(GnRH) agonist protocol versus a short GnRH antagonist protocol.